Reviva Pharmaceuticals Ownership | Who Owns Reviva Pharmaceuticals?


OverviewForecastFinancialsChart

Reviva Pharmaceuticals Ownership Summary


Reviva Pharmaceuticals is owned by 18.71% institutional investors, 4.34% insiders, and 76.96% retail investors. Millennium management is the largest institutional shareholder, holding 5.34% of RVPH shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.75% of its assets in Reviva Pharmaceuticals shares.

RVPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockReviva Pharmaceuticals18.71%4.34%76.96%
SectorHealthcare Stocks 42.51%10.81%46.68%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Millennium management1.80M5.34%$3.27M
Diadema partners lp2.51M5.03%$924.05K
Vanguard group1.92M3.86%$709.67K
Persistent asset partners593.90K1.19%$218.91K
Geode capital management559.24K1.12%$206.17K
Susquehanna group, llp202.01K0.60%$365.64K
Jane street group228.13K0.46%$84.09M
Renaissance216.60K0.43%$79.84K
Blackrock102.93K0.43%$131.75K
Emc capital management128.41K0.39%$49.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Diadema partners lp2.51M0.24%$924.05K
Persistent asset partners593.90K0.15%$218.91K
Emc capital management128.41K0.03%$49.00K
Pale fire capital se25.00K0.00%$32.00K
Nri wealth management lc12.38K0.00%$4.72K
Xtx topco100.40K0.00%$37.01K
Millennium management1.80M0.00%$3.27M
Drive wealth management10.00K0.00%$3.69K
Larson financial group35.00K0.00%$12.90K
Ifp advisors4.90K0.00%$8.87K

Top Buyers

HolderShares% AssetsChange
Jane street group228.13K-228.13K
Renaissance216.60K0.00%216.60K
Susquehanna group, llp202.01K0.00%138.84K
Vanguard group1.92M-119.14K
Geode capital management559.24K-111.04K

Top Sellers

HolderShares% AssetsChange
Armistice capital---2.69M
Heights capital management---1.83M
683 capital management---1.00M
Woodline partners lp---684.80K
Parkman healthcare partners---514.27K

New Positions

HolderShares% AssetsChangeValue
Renaissance216.60K0.00%216.60K$79.84K
Lido advisors99.65K0.00%99.65K$36.73K
Cetera investment advisers60.00K-60.00K$22.12K
Larson financial group35.00K0.00%35.00K$12.90K
Wolverine trading14.26K-14.26K$25.81K

Sold Out

HolderChange
Qube research-50.00
Ubs group-200.00
Jpmorgan chase-235.00
Advisor group-250.00
Wolverine asset management-442.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202543-12.24%9,324,158-34.68%181.01%17-22.73%1011.11%
Jun 30, 202551-3.77%14,278,36798.90%439.18%22-21.43%9-
Mar 31, 2025538.16%7,348,669-4.96%224.24%29-3.33%912.50%
Dec 31, 20244932.43%7,732,309-22.27%222.64%30100.00%8-11.11%
Sep 30, 2024375.71%9,947,22745.22%415.10%15-25.00%980.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.19M1.75%-26.06K
Vanguard US Total Market Shares ETF700.44K1.50%-
Vanguard Institutional Extnd Mkt Idx Tr393.89K0.58%-179.49K
Fidelity Extended Market Index224.04K0.33%-1.84K
BlackRock Extended Equity Market K48.10K0.15%-20.00
Northern Trust Extended Eq Market Idx48.87K0.10%-
NT Ext Equity Mkt Idx Fd - L48.87K0.10%-
Fidelity Total Market Index68.55K0.10%-
iShares Micro-Cap ETF47.06K0.10%-
Extended Equity Market Fund K46.66K0.10%-931.00

Recent Insider Transactions


DateNameRoleActivityValue
Nov 18, 2022Patel Purav-Buy$14.07K
Sep 30, 2022Narayan Prabhu Chief Financial OfficerBuy$83.00K
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$86.96
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$51.38
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$2.09M

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3--
2023 Q4--
2023 Q2--
2022 Q41-

RVPH Ownership FAQ


Who Owns Reviva Pharmaceuticals?

Reviva Pharmaceuticals shareholders are primarily institutional investors at 18.71%, followed by 4.34% insiders and 76.95% retail investors. The average institutional ownership in Reviva Pharmaceuticals's industry, Biotech Stocks , is 45.22%, which Reviva Pharmaceuticals falls below.

Who owns the most shares of Reviva Pharmaceuticals?

Reviva Pharmaceuticals’s largest shareholders are Millennium management (1.8M shares, 5.34%), Diadema partners lp (2.51M shares, 5.03%), and Vanguard group (1.92M shares, 3.86%). Together, they hold 14.23% of Reviva Pharmaceuticals’s total shares outstanding.

Does Blackrock own Reviva Pharmaceuticals?

Yes, BlackRock owns 0.43% of Reviva Pharmaceuticals, totaling 102.93K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 131.75K$. In the last quarter, BlackRock increased its holdings by 11.07K shares, a 12.05% change.

Who is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Diadema partners lp is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.24% of its assets in 2.51M Reviva Pharmaceuticals shares, valued at 924.05K$.

Who is the top mutual fund holder of Reviva Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Reviva Pharmaceuticals shares, with 1.75% of its total shares outstanding invested in 1.19M Reviva Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools